Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

VBP

- PMLiVE

Health research crisis in the NHS is putting patient care at risk

New report highlights importance of research in the health service

- PMLiVE

NICE rejects Akcea’s rare inherited disorder drug Waylivra

Draft guidance deems drug too costly for NHS use

- PMLiVE

NICE knocks back Roche’s Tecentriq for small cell lung cancer

Insufficient evidence to approve use in SCLC on the NHS

- PMLiVE

NHS plans to cut certain routine tests as part of cost-saving efforts

Under proposed plans tests will only be used in exceptional situations

- PMLiVE

Labour clashes with government on ‘NHS for sale’ claims

Government maintains NHS will remain off the table in negotiations

- PMLiVE

Pfizer’s Ibrance scores second-line breast cancer approval via NICE’s Cancer Drugs Fund

Around 3,200 women in England could be eligible for treatment

- PMLiVE

NICE backs first cannabis-based drugs, both from GW Pharma

Approved to treat patients with epilepsy and multiple sclerosis

- PMLiVE

Boris Johnson pledges fast-track visas for key NHS workers

New system will accelerate cut-price visas for doctors and nurses

- PMLiVE

NICE International relaunches, will offer advisory services

Meets growing demand from global health and social care organisations

Digitalising healthcare: what can the NHS learn from other industries?

Expensive digital solutions are often disregarded because they do not work well for the end user. Account Manager Fiona Grace explores this challenge and reveals the stories of innovation we...

Blue Latitude Health

UK vs US: what makes a successful immunisation programme?

Emily Macdonald calls on her experience as a public health nurse specialising in the prevention of infectious disease in both the US and UK, to explore the differences between immunisation...

Blue Latitude Health

- PMLiVE

NICE considering re-evaluation of quality of life assessment

Will address concerns around the watchdog's methodologies

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links